Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
immunology and microbiology
Cost of hospitalisation for non-communicable diseases in India: are we pro-poor?
Tropical Medicine and International Health, Volume 21, No. 8, Year 2016
Notification
URL copied to clipboard!
Description
Objectives: To estimate out-of-pocket (OOP) expenditure due to hospitalisation from NCDs and its impact on households in India. Methods: The study analysed nationwide representative data collected by the National Sample Survey Organisation in 2014 that reported health service utilisation and healthcare-related OOP expenditure by income quintiles and by type of health facility (public or private). The recall period for inpatient hospitalisation expenditure was 365 days. Consumption expenditure was collected for a recall period of 1 month. OOP expenditure amounting to >10% of annual consumption expenditure was termed as catastrophic. Weighted analysis was performed. Results: The median expenditure per episode of hospitalisation due to NCDs was USD 149 – this was ~3 times higher among the richest quintile compared to poorest quintile. There was a significantly higher prevalence of catastrophic expenditure among the poorest quintile, more so for cancers (85%), psychiatric and neurological disorders (63%) and injuries (63%). Mean private-sector OOP hospitalisation expenditure was nearly five times higher than that in the public sector. Medicines accounted for 40% and 27% of public- and private-sector OOP hospitalisation expenditure, respectively. Conclusion: Strengthening of public health facilities is required at community level for the prevention, control and management of NCDs. Promotion of generic medicines, better availability of essential drugs and possible subsidisation for the poorest quintile will be measures to consider to reduce OOP expenditure in public-sector facilities. © 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Authors & Co-Authors
Tripathy, Jaya Prasad
France, Paris
International Union Against Tuberculosis and Lung Disease
Shewade, Hemant Deepak
France, Paris
International Union Against Tuberculosis and Lung Disease
Kumar, Ajay M.V.
France, Paris
International Union Against Tuberculosis and Lung Disease
Zachariah, Rony R.Z.
Switzerland, Geneva
Medecins Sans Frontieres
Chadha, Sarabjit Singh
France, Paris
International Union Against Tuberculosis and Lung Disease
Tonsing, Jamhoih
France, Paris
International Union Against Tuberculosis and Lung Disease
Harries, Anthony David
France, Paris
International Union Against Tuberculosis and Lung Disease
United Kingdom, London
London School of Hygiene & Tropical Medicine
Statistics
Citations: 29
Authors: 7
Affiliations: 3
Identifiers
Doi:
10.1111/tmi.12732
ISSN:
13602276
Research Areas
Health System And Policy
Mental Health
Noncommunicable Diseases
Violence And Injury
Study Design
Cross Sectional Study
Study Approach
Quantitative